Citation 124306

YUSA,K: OH-HARA,T: TSUKAHARA,S: BABA,K: TANIGUCHI,M: KOZAWA,M: TAKEUCHI,S: HARA,H: TSURUO,T:. (1994). INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) REPLICATION BY DAPHNODORINS.. 25(1)

Citation Details

Title	INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) REPLICATION BY DAPHNODORINS.
Authors	YUSA,K: OH-HARA,T: TSUKAHARA,S: BABA,K: TANIGUCHI,M: KOZAWA,M: TAKEUCHI,S: HARA,H: TSURUO,T:
Year	1994
Volume	25
Issue	1

Summary

Year: 1994

Journal: Unknown

Organisms and Their Experiments (3)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DAPHNODORIN A	ACTIVE
2	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAPHNODORIN A	WEAK ACTIVITY
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAPHNODORIN A	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DAPHNODORIN B	ACTIVE
2	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAPHNODORIN B	INACTIVE
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAPHNODORIN B	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DAPHNODORIN B	ACTIVE
2	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAPHNODORIN C	WEAK ACTIVITY
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAPHNODORIN C	INACTIVE

Show SPARQL Queries (1)